课题基金 / 基金详情

Molecular Mechanisms of Genomic Reprogramming during Germ Cell Specification

Molecular Mechanisms of Genomic Reprogramming during Germ Cell Specification
生殖细胞规范过程中基因组重编程的分子机制
批准号:
8097319
负责人:
Sujata Bhattacharyya
金额:
$5.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2012-07-31

项目摘要

项目成果

Sujata Bhattacharyya的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):生殖细胞的显著之处在于,在生物体中发现的所有细胞类型中,它们单独保留产生有助于生物体的所有胚胎和胚外细胞类型的能力。这种全能性的特性在原始生殖细胞(PGCs)中通过维持转录抑制的基因组而得到保护。两个时间和生化不同的机制实现这一目标,在C。优雅最初,秀丽隐杆线虫特异性母体蛋白PIE-1,特异性分配到生殖系卵裂球,抑制RNA聚合酶的激活。在PGC产生后不久,PIE-1被降解,并且发生显著的全基因组染色质重塑以维持转录抑制。然而,参与调节基因组整体重塑效应的途径仍然未知。这项计划的一个重要目标是揭示新生生殖细胞中各种活性染色质标记物特异性丢失的分子机制。RNA聚合酶,组蛋白变体和翻译后修饰的作用将在这些擦除事件的控制中进行询问。最初的实验还表明,在原始生殖细胞Z2和Z3出生时,组蛋白脱乙酰酶(HDAC)活性被特异性激活。在互补的方法,使用功能丧失突变体,RNA干扰和转基因错误表达,持续组蛋白乙酰化的后果的种系将被阐明。最后,HDAC活性的翻译和翻译后控制将使用遗传和生物化学方法进行探测。 公共卫生相关性:这些研究解决了一个与生物医学相关的基本问题:胚胎细胞以及干细胞如何保持分化成成年动物所有谱系的能力?这个问题的答案无疑将对操纵细胞产生组织特异性祖细胞产生巨大的影响,这些祖细胞最终可用于治疗帕金森氏症等衰弱性退行性疾病。此外,由于组蛋白去乙酰化与癌细胞中的异常基因沉默有关,HDAC抑制剂正在开发为有效的抗癌药物,因此我们的长期目标是利用我们对组蛋白去乙酰化调节的了解来增加下一代表观遗传疗法的特异性。
英文摘要
DESCRIPTION (provided by applicant): Germ cells are remarkable in that, of all the cell types found in an organism they alone retain the ability to give rise to all the embryonic and extra-embryonic cell types that contribute to an organism. This property of totipotency is protected in primordial germ cells (PGCs) by their maintenance of a transcriptionally repressed genome. Two temporally and biochemically distinct mechanisms accomplish this objective in C. elegans. Initially, a C.elegans-specific maternal protein PIE-1, specifically partitioned to the germ line blastomeres, inhibits activation of RNA polymerase. Shortly, after the birth of the PGCs, PIE-1 is degraded and dramatic genome-wide chromatin remodeling occurs to sustain transcriptional repression. However, pathways involved in regulating effectors of global remodeling of the genome remain unknown. A significant goal of this proposal is to uncover molecular mechanisms underlying the specific loss of various marks of 'active' chromatin in newly bom germ cells. The role of RNA polymerase, histone variants and post-translational modifications will be interrogated in the control of these erasure events. Initial experiments also suggest specific activation of histone deacetylase (HDAC) activity at the birth of the primordial germ cells, Z2 and Z3. In complementary approaches, using loss-of-function mutants, RNA interference and transgenic misexpression, the consequence of persistent histone acetylation on the germ-line will be elucidated. Finally, translational and post-translational control of HDAC activity will be probed using genetic and biochemical approaches. Public Health Relevance: These studies address a fundamental question of biomedical relevance: how do embryonic cells, and for that matter, stem cells retain the ability to differentiate into all lineages of the adult animal? The answer to this question will undoubtedly have enormous ramifications for manipulating cells to generate tissue-specific progenitors that could ultimately be used to cure debilitating, degenerative illnesses such as Parkinson's. Additionally, since histone deacetylation has been implicated in aberrant gene silencing in cancerous cells and HDAC inhibitors are being developed as effective anti-cancer drugs, our long-term goal is to utilize our knowledge of histone deacetylation regulation to increase the specificity of next generation epigenetic therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms of Genomic Reprogramming during Germ Cell Specification
  • 批准号:
    7920163
  • 项目类别:
  • 资助金额:
    $5.99万
  • 财政年份:
    2009
  • 负责人:
    Sujata Bhattacharyya
  • 依托单位:
Molecular Mechanisms of Genomic Reprogramming during Germ Cell Specification
  • 批准号:
    7752883
  • 项目类别:
  • 资助金额:
    $5.79万
  • 财政年份:
    2009
  • 负责人:
    Sujata Bhattacharyya
  • 依托单位:
海外基金